Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Deferred Taxes (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Deferred Taxes for 16 consecutive years, with -$35.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Deferred Taxes fell 407.24% to -$35.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$32.3 million, a 147.64% decrease, with the full-year FY2025 number at -$32.3 million, down 147.64% from a year prior.
  • Deferred Taxes was -$35.6 million for Q4 2025 at Acadia Healthcare Company, down from $12.1 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $21.5 million in Q2 2024 to a low of -$72.3 million in Q4 2023.
  • A 5-year average of -$1.8 million and a median of $3.6 million in 2021 define the central range for Deferred Taxes.
  • Peak YoY movement for Deferred Taxes: tumbled 597.62% in 2023, then skyrocketed 15856.3% in 2024.
  • Acadia Healthcare Company's Deferred Taxes stood at $4.3 million in 2021, then crashed by 338.67% to -$10.4 million in 2022, then crashed by 597.62% to -$72.3 million in 2023, then skyrocketed by 116.0% to $11.6 million in 2024, then plummeted by 407.24% to -$35.6 million in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Deferred Taxes are -$35.6 million (Q4 2025), $12.1 million (Q3 2025), and -$3.1 million (Q2 2025).